Findings from a study published in the July/August 2008 issue of the Aesthetic Surgery Journal show a marked improvement in quality of life for patients who underwent breast reduction surgery, indicating that benefits of the procedure go beyond the mere aesthetic result.
PEAK Surgical, Inc., a medical device company that has developed a new tissue dissection system based on a proprietary technology, announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its PEAK(R) Surgery System for use in general surgery. The PEAK Surgery System combines the PULSAR(TM) Generator, which supplies pulsed plasma radiofrequency energy, with the PEAK PlasmaBlade(TM) 4.0, a low-temperature surgical cutting and coagulation tool. This tissue dissection system will be commercially available next month.
